Trial Profile
NPC1L1 gene polymorphism on the effect of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 28 Dec 2015 New trial record